|
656791fc212eaade2e0ec678
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020023640
|
76_65489
|
1
|
Democratic Republic of the Con...go
more
|
South of Sahara
|
LDCs
|
ODA Grants
|
1
|
10
|
110
|
C01
|
5.865252
|
0
|
0
|
0
|
5.865252
|
0
|
0
|
5.865252
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
TUBERCULOSIS LOCAL ORGANIZATIO...NS NETWORK IN DRC
more
|
Tuberculosis Local Organizatio...ns Network in DRC
more
|
Technical assistance and fundi...ng to support the prevention, care and treatment of TB in six provinces: Tanganyika, Central Kasai, Sankuru, Kasai Oriental, Lomami, and South Kivu. The Activity goal is to expand access to comprehensive TB services at the he
more
|
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Sante Pour Tous et Par Tous
|
|
|
|
656791fc212eaade2e0ec679
|
2020
|
United Kingdom
|
Department for Business, Innov...ation and Skills
more
|
2020008272
|
BBSRC_NS_BB/N003594/1
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.022351
|
0
|
0
|
0
|
0.022351
|
0
|
0
|
0
|
0
|
Communicable diseases
|
Communicable diseases Research... and Development
more
|
100
|
DOES ACOUSTIC SIGNALLING PREDI...CT MATING SUCCESS IN MOSQUITO LINES?
more
|
Does acoustic signalling predi...ct mating success in mosquito lines?
more
|
The control of mosquito transm...itted diseases such as malaria, dengue fever, and Chikungunya is still largely dependent on mosquito population control. This project will inform new strategies to manage mosquito populations through genetic and reproductive control.
more
|
partially NTDs
|
12182
|
Medical research
|
|
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University, college or other t...eaching institution, research institute or think?tank
more
|
|
|
|
656791fc212eaade2e0ec67a
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008273
|
76_36742
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
|
-0.05
|
Communicable diseases
|
Tuberculosis
|
100
|
TUBERCULOSIS
|
Tuberculosis
|
Reduce the number of deaths ca...used by TB by increasing detection of cases of TB and by successfully treating detected cases, as well as addressing issues of multi-drug resistant TB, TB and HIV, and investing in new tools for TB.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Enterprise - United States Oth...er
more
|
|
|
|
656791fd212eaade2e0ec67b
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008554C
|
76_40105
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D01
|
0
|
6.956521
|
0
|
0
|
0
|
6.956521
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
TECHNOLOGY, RESEARCH, EDUCATIO...N AND TECHNICAL ASSISTANCE FOR TUBERCULOSIS (TREAT TB)
more
|
Technology, Research, Educatio...n and Technical Assistance for Tuberculosis (TREAT TB)
more
|
Technology, Research, Educatio...n and Technical Assistance for Tuberculosis (TREAT TB) is a cooperative agreement with the International Union Against Tuberculosis and Lung Disease (IUATLD), also known as The Union. TREAT TB focuses on field evaluations of diagnostic techniques for TB, clinical trials and operations research to improve patient management, treatment efficacy, disease prevention, and infection control measures for TB and MDR TB. TREAT TB also provides for field support to address key TB and TB/HIV issues through operational research to improve the national TB programs performance.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
21034
|
International Union Against Tu...berculosis and Lung Disease
more
|
International Union Against Tu...berculosis and Lung Disease
more
|
|
|
|
656791fd212eaade2e0ec67c
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008554A
|
76_40105
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D01
|
2
|
3.852479
|
0
|
0
|
2
|
3.852479
|
0
|
|
|
2
|
Communicable diseases
|
Tuberculosis
|
100
|
TECHNOLOGY, RESEARCH, EDUCATIO...N AND TECHNICAL ASSISTANCE FOR TUBERCULOSIS (TREAT TB)
more
|
Technology, Research, Educatio...n and Technical Assistance for Tuberculosis (TREAT TB)
more
|
Technology, Research, Educatio...n and Technical Assistance for Tuberculosis (TREAT TB) is a cooperative agreement with the International Union Against Tuberculosis and Lung Disease (IUATLD), also known as The Union. TREAT TB focuses on field evaluations of diagnostic techniques for TB, clinical trials and operations research to improve patient management, treatment efficacy, disease prevention, and infection control measures for TB and MDR TB. TREAT TB also provides for field support to address key TB and TB/HIV issues through operational research to improve the national TB programs performance.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
21034
|
International Union Against Tu...berculosis and Lung Disease
more
|
International Union Against Tu...berculosis and Lung Disease
more
|
|
|
|
656791fd212eaade2e0ec67d
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008783O
|
76_42705
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
5.031333
|
0
|
0
|
0
|
5.031333
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
WORLD HEALTH ORGANIZATION CONS...OLIDATED GRANT
more
|
World Health Organization Cons...olidated Grant
more
|
This grant provides support fo...r collaborative activities with USAID and the World Health Organization (WHO) in infectious diseases, maternal and child health, family planning, safe motherhood, reproductive health, environmental health and HIV/AIDS. Specifically, support is provided to WHOs relevant technical and program divisions for technical input and assistance in the development, implementation and/or evaluation of health programs and studies including: 1) Global strategy development, 2) Technical analyses, 3) Demonstration activities and feasibility studies, 4) Capacity building, 5) Policy reform, 6) Project evaluation and assessments, 7) Monitoring and evaluation, 8) Education/information strategies, 9) Maternal and neonatal health, 10) Family Planning and Reproductive Health, 11) Implementing Best Practices in Family Planning, and 11) Medical Eligibility Criteria (MEC).
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
41307
|
World Health Organisation - as...sessed contributions
more
|
World Health Organisation - as...sessed contributions
more
|
|
|
|
656791fd212eaade2e0ec67e
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020008783T
|
76_42705
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
0.960247
|
0
|
0
|
0
|
0.960247
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
WORLD HEALTH ORGANIZATION CONS...OLIDATED GRANT
more
|
World Health Organization Cons...olidated Grant
more
|
This grant provides support fo...r collaborative activities with USAID and the World Health Organization (WHO) in infectious diseases, maternal and child health, family planning, safe motherhood, reproductive health, environmental health and HIV/AIDS. Specifically, support is provided to WHOs relevant technical and program divisions for technical input and assistance in the development, implementation and/or evaluation of health programs and studies including: 1) Global strategy development, 2) Technical analyses, 3) Demonstration activities and feasibility studies, 4) Capacity building, 5) Policy reform, 6) Project evaluation and assessments, 7) Monitoring and evaluation, 8) Education/information strategies, 9) Maternal and neonatal health, 10) Family Planning and Reproductive Health, 11) Implementing Best Practices in Family Planning, and 11) Medical Eligibility Criteria (MEC).
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
41307
|
World Health Organisation - as...sessed contributions
more
|
World Health Organisation - as...sessed contributions
more
|
|
|
|
656791fd212eaade2e0ec67f
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020009152H
|
76_45853
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-1.0E-6
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
GLOBAL HEALTH FELLOWS PROGRAM ...II (GHFP-II)
more
|
Global Health Fellows Program ...II (GHFP-II)
more
|
GHFP-II, led by the Public Hea...lth Institute (PHI), helps USAID address its immediate and emerging human capital needs by developing a diverse group of global health professionals to support and sustain the effectiveness of the Agencys current and future health programs. This cadre of global health talent is motivated, technically excellent, well-supported, representative of the diversity of the American people, and committed to contributing to USAIDs success in key global health priority areas.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
656791fd212eaade2e0ec680
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020009324E
|
76_47515
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.01
|
0
|
0
|
0
|
0.01
|
-0.01
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
ADVANCING PARTNERS AND COMMUNI...TY-BASED FAMILY PLANNING
more
|
Advancing Partners and Communi...ty-based Family Planning
more
|
Advancing Partners & Communiti...es advances and supports community programs that seek to improve the overall health of communities and achieve other health-related impacts, especially in relationship to family planning.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
John Snow International
|
|
|
|
656791fd212eaade2e0ec681
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020009909G
|
76_50250
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.042939
|
0
|
0
|
0
|
0.042939
|
0
|
|
|
-0.084127
|
Communicable diseases
|
Tuberculosis
|
100
|
PROCUREMENT SUPPORT AWARD (PSA...)
more
|
Procurement Support Award (PSA...)
more
|
USAIDs Bureau for Global Healt...h awarded Jefferson Solutions (Jefferson) the Procurement Support Award (PSA), a five-year support contract, in July 2013. The PSA allows Global Health and the USAID Missions to quickly access dedicated resources to support acquisition and assistance (A&A) efforts for Global Health-funded and health-related projects. The PSA is also able to provide additional project support on an as-requested basis.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Enterprise - United States Red...acted
more
|
|
|
|
656791fd212eaade2e0ec682
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020010020D
|
76_50526
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.0158
|
0.004517
|
0
|
0
|
0.0158
|
0.004517
|
0
|
|
|
0.0158
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID ADVISORY AND ASSISTANCE ...SERVICES
more
|
USAID Advisory and Assistance ...Services
more
|
Administrative costs and opera...ting expenses of USAID contributing to Advisory and Assistance Services.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
656791fe212eaade2e0ec683
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020010602B
|
76_50715
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.001
|
0.001
|
0
|
0
|
0.001
|
0.001
|
0
|
|
|
0.001
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID ADVISORY AND ASSISTANCE ...SERVICES
more
|
USAID Advisory and Assistance ...Services
more
|
Administrative costs and opera...ting expenses of USAID contributing to Advisory and Assistance Services.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Invitational Travelers - USAID
|
|
|
|
656791fe212eaade2e0ec684
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020010694B
|
76_50913
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
9.0E-6
|
9.0E-6
|
0
|
0
|
9.0E-6
|
9.0E-6
|
0
|
|
|
9.0E-6
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID CLAIMS, INCOME, AND REFU...NDS
more
|
USAID Claims, Income, and Refu...nds
more
|
Administrative costs and opera...ting expenses of USAID contributing to Claims, Income, and Refunds.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
656791fe212eaade2e0ec685
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020010878G
|
76_50944
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.230489
|
0
|
0
|
0
|
0.230489
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID COMMUNICATIONS, UTILITIE...S, AND RENTAL PAYMENTS
more
|
USAID Communications, Utilitie...s, and Rental Payments
more
|
Administrative costs and opera...ting expenses of USAID contributing to Communications, Utilities, and Rental Payments.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
656791fe212eaade2e0ec686
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020011055D
|
76_50975
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
|
-0.000367
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID COMMUNICATIONS, UTILITIE...S, AND RENTAL PAYMENTS
more
|
USAID Communications, Utilitie...s, and Rental Payments
more
|
Administrative costs and opera...ting expenses of USAID contributing to Communications, Utilities, and Rental Payments.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Enterprise - United States Red...acted
more
|
|
|
|
656791fe212eaade2e0ec687
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020012899Q
|
76_51685
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.525267
|
0.525267
|
0
|
0
|
0.525267
|
0.525267
|
0
|
|
|
0.525267
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID PAY AND BENEFITS
|
USAID Pay and Benefits
|
Administrative costs and opera...ting expenses of USAID contributing to Payrolls and Benefits.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
656791fe212eaade2e0ec688
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020012965K
|
76_51687
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D02
|
0.14151
|
0.129903
|
0
|
0
|
0.14151
|
0.129903
|
0
|
|
|
0.14151
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID PAY AND BENEFITS
|
USAID Pay and Benefits
|
Administrative costs and opera...ting expenses of USAID contributing to Payrolls and Benefits.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
656791fe212eaade2e0ec689
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020013111G
|
76_51695
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.04047
|
0.039936
|
0
|
0
|
0.04047
|
0.039936
|
0
|
|
|
0.04047
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID PAY AND BENEFITS
|
USAID Pay and Benefits
|
Administrative costs and opera...ting expenses of USAID contributing to Payrolls and Benefits.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
656791ff212eaade2e0ec68a
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020013727T
|
76_51839
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.007744
|
0.012346
|
0
|
0
|
0.007744
|
0.012346
|
0
|
|
|
0.007744
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID TRAVEL AND TRANSPORTATIO...N
more
|
USAID Travel and Transportatio...n
more
|
Administrative costs and opera...ting expenses of USAID contributing to Travel and Transportation.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
656791ff212eaade2e0ec68b
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020014543E
|
76_52017
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.000435
|
0.000435
|
0
|
0
|
0.000435
|
0.000435
|
0
|
|
|
0.000435
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID TRAVEL AND TRANSPORTATIO...N
more
|
USAID Travel and Transportatio...n
more
|
Administrative costs and opera...ting expenses of USAID contributing to Travel and Transportation.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Enterprise - United States Red...acted
more
|
|
|
|
656791ff212eaade2e0ec68c
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020014788A
|
76_52366
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D01
|
0
|
2.599605
|
0
|
0
|
0
|
2.599605
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
CHALLENGE TUBERCULOSIS (TB)
|
Challenge Tuberculosis (TB)
|
Challenge TB runs from Septemb...er 30, 2014 until September 29, 2019 and will align with the WHO post-2015 Global TB Strategy and the new United States Government TB Strategy to enhance focus on improving patient-centered quality TB services, building local capacity and the utilization of innovations and new technologies to move forward in the global fight against TB. Challenge TB will have three main objectives: 1. Improve patient-centered quality care and services for TB, 2. Sustain and enhance systems, and 3. Transmission and disease prevention.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - Non United States Redact...ed
more
|
|
|
|
656791ff212eaade2e0ec68d
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020014896C
|
76_52704
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.31012
|
0
|
0
|
0
|
0.31012
|
0
|
|
|
-0.289881
|
Communicable diseases
|
Tuberculosis
|
100
|
GLOBAL HEALTH PROGRAM CYCLE IM...PROVEMENT PROJECT (GH PRO)
more
|
Global Health Program Cycle Im...provement Project (GH Pro)
more
|
The Global Health Program Cycl...e Improvement Project (GH Pro) is a five-year contract that is available to the Bureau for Global Health offices, regional and other bureaus, and field missions of USAID in health program assessment, design, monitoring and evaluation, and program support. GH Pro works across USAID's health portfolio in support of its goals of preventing and managing major health challenges of poor, underserved, and vulnerable people, leading to improved health outcomes. In support of these goals, the project also advances expertise in cross-cutting health issues such as gender, health systems strengthening, and science and technology.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Enterprise - United States Red...acted
more
|
|
|
|
656791ff212eaade2e0ec68e
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020015033N
|
76_52912
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D01
|
0
|
0.019825
|
0
|
0
|
0
|
0.019825
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
M&E CAPACITY BUILDING (MECAP)
|
M&E Capacity Building (MECap)
|
MECap supports evidence-based ...decision making and improving USAID program effectiveness and development outcomes by strengthening monitoring and evaluation as part of the USAID Program Cycle. The purpose is to support the planning, conduct and use of high quality monitoring and evaluation (M&E) by USAID staff and partners to improve the effectiveness of USAID programs in achieving significant development outcomes. MECap fills a critical need for technical assistance, guidance and specialized expertise in state-of-the-art monitoring and evaluation methodologies and practices as applied in an international context.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Social Solutions International..., Inc.
more
|
|
|
|
656791ff212eaade2e0ec68f
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020015053I
|
76_52920
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.08821
|
0
|
0
|
0
|
0.08821
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
MPI- G8 INVESTMENT SUPPORT PRO...GRAM
more
|
MPI- G8 Investment Support Pro...gram
more
|
The USAID Investment Support P...rogram (ISP) serves as the keystone award for USAID's efforts to provide a full range of financial and investment services to potential investors, private sector actors, host government organizations, USAID field missions throughout the world, and USAID geographic and pillar bureaus. This activity will focus on mobilizing private sector capital towards opportunities that can generate an economic and social impact. This program is global in scope, with potential activities in any country and/or region where USAID operates. It is also open to engaging in any economic sector, in support of current and future Agency priorities. It is anticipated that at least 50% of this program's funding will be dedicated to agriculture activities in support of the Feed the Future Initiative.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Dalberg Global Development Adv...isors
more
|
|
|
|
656791ff212eaade2e0ec690
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020015104G
|
76_52978
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.163625
|
0
|
0
|
0
|
0.163625
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
MEASURE EVALUATION IV
|
Measure Evaluation IV
|
The Monitoring and Evaluation ...to Assess and Use Results (MEASURE) Evaluation Phase IV Project builds on the decades-long commitment by the Bureau for Global Health to support health sector monitoring and evaluation and country health information system strengthening. The project is designed, in part, to further efforts of the U.S. Agency for International Development (USAID) to end preventable child and maternal deaths (EPCMD) by assisting partner governments and institutions to generate and make use of high-quality health systems data that can be used to guide decision-making on effective interventions. The strategic objective of the MEASURE Evaluation Phase IV Project is to enable countries to strengthen national, community, and facility-based systems to generate high quality health information that is used to inform decisions on policies, programs, and resource allocations at all levels of the health system.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University of North Carolina, ...Chapel Hill
more
|
|
|
|
65679200212eaade2e0ec691
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020015218G
|
76_53363
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.016515
|
0
|
0
|
0
|
0.016515
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
PROJECT LAST MILE GDA
|
Project Last Mile GDA
|
USAID, the Coca-Cola Company, ...the Global Fund to Fight AIDS Tuberculosis and Malaria, and the Bill and Melinda Gates Foundation established an alliance called Project Last Mile (PLM) which leverages the proprietary business intelligence and experience of the Coca-Cola system to improve access to life-saving medicines and critical medical supplies at the 'last mile' of African nations. PLM is working with African governments and partners in 8 countries, including South Africa, Swaziland, Mozambique, Nigeria, Tanzania, Liberia, and Sierra Leone.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Global Environment & Technolog...y Foundation
more
|
|
|
|
65679200212eaade2e0ec692
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020015601F
|
76_54831
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
|
-0.022
|
Communicable diseases
|
Tuberculosis
|
100
|
ENGAGE HCD (HUMAN-CENTERED DES...IGN)
more
|
Engage HCD (Human-Centered Des...ign)
more
|
Human-centered design (HCD) pl...aces the target population and other important stakeholders at the center of the design and implementation process. HCD was developed in the private sector to integrate business and technology around human needs. There are two ways to leverage HCD in global health development work: designing for user needs (target the right user group for an offering or intervention, drive the adoption and scale-up of new health behaviors, and rapidly conceptualize, prototype, and test new interventions and ensure they are viable for the provider) and improving collaboration across diverse stakeholders (establish and communicate a shared mission and vision across stakeholders, create and promote methods within teams for increased collaboration, and improve data usage to support shared decision-making). Examples of this work include: driving demand for the use of chlorhexidine, and increasing the uptake of the dapivarine ring.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Dalberg Global Development Adv...isors
more
|
|
|
|
65679200212eaade2e0ec693
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020015888C
|
76_55118
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.415174
|
0.165149
|
0
|
0
|
0.415174
|
0.165149
|
0
|
|
|
0.415174
|
Communicable diseases
|
Tuberculosis
|
100
|
INTER-AGENCY AGREEMENT (IAA) W...ITH HHS/CDC
more
|
Inter-Agency Agreement (IAA) w...ith HHS/CDC
more
|
The umbrella Interagency Agree...ment (IAA) with CDC allows USAID to access technical expertise from CDC, a world-renowned source of specialized technical experience and expertise in the international health field. The IAA supports activities in the control and prevention of infectious diseases including tuberculosis, malaria, disease surveillance, antimicrobial resistance, neglected tropical diseases, and environmental health.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
65679200212eaade2e0ec694
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020016144A
|
76_55689
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
50.626389
|
17.536405
|
0
|
0
|
50.626389
|
17.536405
|
0
|
50.626389
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
UNOPS STOP TB PARTNERSHIP
|
UNOPS Stop TB Partnership
|
To enhance the capacity of Tun...isian health system to respond efficiently to community transmission of COVID-19 while protecting health workers and vulnerable groups and ensuring the delivery of COVID-19 related health services through strengthening: national screening and laboratory capacity, case management, and infection prevention and control measures.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
41300
|
|
United Nations Office for Proj...ect Services
more
|
|
|
|
65679200212eaade2e0ec695
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020016144H
|
76_55689
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
B03
|
0
|
4.220783
|
0
|
0
|
0
|
4.220783
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
UNOPS STOP TB PARTNERSHIP
|
UNOPS Stop TB Partnership
|
To enhance the capacity of Tun...isian health system to respond efficiently to community transmission of COVID-19 while protecting health workers and vulnerable groups and ensuring the delivery of COVID-19 related health services through strengthening: national screening and laboratory capacity, case management, and infection prevention and control measures.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
41300
|
|
United Nations Office for Proj...ect Services
more
|
|
|
|
65679200212eaade2e0ec696
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020016212
|
76_55940
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.446393
|
0.255514
|
0
|
0
|
0.446393
|
0.255514
|
0
|
|
|
0.446393
|
Communicable diseases
|
Tuberculosis
|
100
|
USAID PAY AND BENEFITS
|
USAID Pay and Benefits
|
Administrative costs and opera...ting expenses of USAID contributing to Payrolls and Benefits.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
Emory University
|
|
|
|
65679200212eaade2e0ec697
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020016578I
|
76_56704
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.150815
|
0.286291
|
0
|
0
|
0.150815
|
0.286291
|
0
|
|
|
0.150815
|
Communicable diseases
|
Tuberculosis
|
100
|
GLOBAL HEALTH PROFESSIONAL AND... ORGANIZATIONAL DEVELOPMENT (GHPOD) II PROGRAM
more
|
Global Health Professional and... Organizational Development (GHPOD) II program
more
|
Under a five-year contract wit...h USAID, EnCompass manages the Global Health Professional and Organizational Development (GHPOD) II program. GHPODs role is to provide professional and organizational development support to USAIDs health sector staff around the world to build their capacity to lead and manage health programs. Through the GHPOD mechanism, EnCompass provides a variety of training and learning programs to build capacity in technical areas, program management, leadership, personal and team effectiveness, retreats and strategic meetings, and staff performance management. Each year GHPOD II designs and delivers as many as 45 professional development programs and 50 OD interventions, and provides coaching to about 60 USAID global health professionals.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
EnCompass, LLC
|
|
|
|
65679201212eaade2e0ec698
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020016610K
|
76_56709
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
3.869461
|
5.922407
|
0
|
0
|
3.869461
|
5.922407
|
0
|
3.869461
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
GLOBAL HEALTH SUPPORT INITIATI...VES III (GHSI-III)
more
|
Global Health Support Initiati...ves III (GHSI-III)
more
|
Global Health Support Initiati...ves III (GHSI-III) procurement. GHSI-III is the successor to GHSI-II. GHSI III will provide non-direct hire global health support services for USAID's Bureau for Global Health (GH) at its offices in Washington, D.C. and overseas. The activity will recruit, hire and maintain a contracted technical, professional, operational, and support staff that supply support services to USAID's health programs worldwide. The staff provided under the activity will support seven health program areas: (1) HIV/AIDS, (2) Tuberculosis, (3) Malaria, (4) Avian Influenza, (5) Other Public Health Threats, (6) Maternal and Child Health, and (7) Family Planning and Reproductive Health.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Social Solutions International..., Inc.
more
|
|
|
|
65679201212eaade2e0ec699
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020016993E
|
76_57213
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.27
|
0
|
0
|
0
|
0.27
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
SCALE FOR IMPACT
|
Scale for Impact
|
To accelerate and magnify the ...impact of priority global health innovations, CII pairs the most successful private sector principles and practices within the global health context. To scale for impact, our approach includes: Planning for introduction and scale, Utilization of innovative financing, Shaping markets, Leveraging the private sector, Successful product introduction and scale-up requires the application of multiple technical specializations across the design, development, introduction, and scale-up continuum. The objective of the Scale for Impact program is the rapid development and diffusion of innovations by ensuring timely and appropriate planning for priority global health products and technologies. This contracting vehicle provides access to product introduction & scale-up planning, facilitating, and capacity building services to support the development of global health products/technologies, service delivery models, and other approaches that can be efficiently and effectively scaled.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Boston Consulting Group, Inc.
|
|
|
|
65679201212eaade2e0ec69a
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020017057
|
76_57317
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.047302
|
0
|
0
|
0
|
0.047302
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
TB COMMUNICATIONS AWARD II
|
TB Communications Award II
|
The TB Communications Award pr...ovides communications services to assist the USAID TB Team in describing its work to a variety of audiences. LRG provides communications and publishing services to effectively describe the work of the TB Team to a variety of audiences. By designing and producing reports, creating media materials and executing events, the TB teams efforts can reach a wider audience thereby making a bigger impact. The needs of the team include publications such as an annual report to Congress,.implementation of a communications plan for World TB Day, materials for other TB events throughout the year, and the production of media materials. The contractor works with the TB team to strategically plan for new ways to better communicate USAIDs efforts.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
11001
|
Central Government
|
Central Government
|
|
|
|
65679201212eaade2e0ec69b
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020017109Q
|
76_57340
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0
|
0.046963
|
0
|
0
|
0
|
0.046963
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
THE DIGITAL HEALTH INITIATIVE ...(DIGITAL SQUARE)
more
|
The digital health initiative ...(Digital Square)
more
|
Digital Square works to create... a future where governments and decision-makers can access the information they need to ensure better health outcomes for all. The activity aims to perpetuate the pilot programs by aligning donors and the digital community around shared goals, supporting technical capacity in-country, coordinating and aligning investments around government priorities to achieve lasting impact, and promoting the reuse and adaptation of existing open-source digital health solutions. In Bangladesh, the activity will use FY17 funds to continue providing technical assistance to the Ministry of Health and Family Welfare (MoHFW) to maintain the operations of the digitized supply chain management systems developed by USAID in the last six years. Digital Square will work with a local Information Technology firm to assist MoHFW to maintain and use the system for procurement planning..
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65679201212eaade2e0ec69c
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020017109I
|
76_57340
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.17311
|
0
|
0.043733
|
0
|
0.17311
|
0
|
0.043733
|
0.17311
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
THE DIGITAL HEALTH INITIATIVE ...(DIGITAL SQUARE)
more
|
The digital health initiative ...(Digital Square)
more
|
Digital Square works to create... a future where governments and decision-makers can access the information they need to ensure better health outcomes for all. The activity aims to perpetuate the pilot programs by aligning donors and the digital community around shared goals, supporting technical capacity in-country, coordinating and aligning investments around government priorities to achieve lasting impact, and promoting the reuse and adaptation of existing open-source digital health solutions. In Bangladesh, the activity will use FY17 funds to continue providing technical assistance to the Ministry of Health and Family Welfare (MoHFW) to maintain the operations of the digitized supply chain management systems developed by USAID in the last six years. Digital Square will work with a local Information Technology firm to assist MoHFW to maintain and use the system for procurement planning..
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Redacted
|
|
|
|
65679201212eaade2e0ec69d
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020017558I
|
76_58217
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.05916
|
0.039974
|
0
|
0
|
0.05916
|
0.039974
|
0
|
0.05916
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
BREAKTHROUGH-ACTION
|
Breakthrough-ACTION
|
Breakthrough-ACTION will use s...tate-of-the-art, evidence-based tools to encourage people in developing countries to adopt healthy behaviors, from using modern contraceptive methods to sleeping under bed nets to being tested for HIV. Much of the work will harness the power of communication - from mass media campaigns to TV and radio dramas to simple posters in a health clinic - to inspire long-lasting change. The project will also take advantage of other behavioral science approaches such as behavioral economics and human-centered design to improve programs. The program - which builds on a prior five-year, 31-country project called the Health Communication Capacity Collaborative (HC3) - is expected to be double the size. It will be led by CCP who will partner with Save the Children, ideas42, ThinkPlace Kenya and Camber Collective. Breakthrough-ACTION will also be supported in the field by ActionSprout, the International Center for Research on Women and Human Network International. CCP is based at the Johns Hopkins Bloomberg School of Public Health.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University/Research Institute ...- United States Redacted
more
|
|
|
|
65679201212eaade2e0ec69e
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020017921S
|
76_58736
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.004
|
0
|
0
|
0
|
0.004
|
0
|
0
|
|
|
0.004
|
Communicable diseases
|
Tuberculosis
|
100
|
INVEST
|
INVEST
|
INVEST is a flexible, efficien...t buy-in mechanism that helps USAID operating units mobilize private capital to achieve their goals. Through INVEST, USAID accesses the expertise it needs to evaluate and execute blended finance approaches. This supports USAIDs focus on enterprise-led development, unlocking the potential of the private sector to move countries beyond the need for assistance. INVEST was designed to directly address operational challenges that usually inhibit USAID from working alongside the investment community. It ensures rapid procurementwithin four to six weeksso USAID can act within investors short timelines. It enables flexible, specialized project design and implementation. It provides access to partners with localized expertise in investment and development. And, it focuses on learning and adaptation to drive innovation in blended finance.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Development Alternatives, Inc.
|
|
|
|
65679202212eaade2e0ec69f
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020018590P
|
76_59466
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.00735
|
0
|
0
|
0
|
0.00735
|
0
|
0
|
|
|
0.00735
|
Communicable diseases
|
Tuberculosis
|
100
|
TECHNICAL AND ADMINISTRATIVE S...UPPORT CONTRACT II
more
|
Technical and Administrative S...upport Contract II
more
|
This activity is a staffing me...chanism providing support to eight E3 technical offices, the E3 Front Office, E3 Professional Development and Management Services (PDMS) and E3 Planning, Learning and Coordination (PLC). Professional and technical staff are classified within various employment categories, such as administrative support, economists, programming staff.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
ZemiTek
|
|
|
|
65679202212eaade2e0ec6a0
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020018622
|
76_59559
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.105
|
0
|
0
|
0
|
0.105
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
TUBERCULOSIS
|
Tuberculosis
|
Reduce the number of deaths ca...used by TB by increasing detection of cases of TB and by successfully treating detected cases, as well as addressing issues of multi-drug resistant TB, TB and HIV, and investing in new tools for TB.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
NGO - United States Other
|
|
|
|
65679202212eaade2e0ec6a1
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020018715M
|
76_59767
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.011071
|
0.011071
|
0
|
0
|
0.011071
|
0.011071
|
0
|
|
|
0.011071
|
Communicable diseases
|
Tuberculosis
|
100
|
AAAS SCIENCE & TECHNOLOGY POLI...CY FELLOWSHIP PROGRAM AT USAID
more
|
AAAS Science & Technology Poli...cy Fellowship Program at USAID
more
|
The purpose of the AAAS agreem...ent is to benefit from the expertise and analytical skills of Ph.D. scientists and engineers and, in turn, provide Fellows with an opportunity to gain policy making experience at the Federal level.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
All Native Managed Services
|
|
|
|
65679202212eaade2e0ec6a2
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019094G
|
76_60347
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.125165
|
0.010333
|
0
|
0
|
0.125165
|
0.010333
|
0
|
|
|
0.125165
|
Communicable diseases
|
Tuberculosis
|
100
|
DATA FOR IMPACT (D4I)
|
Data for Impact (D4I)
|
The USAID-funded Data for Impa...ct (D4I) project is a mechanism for monitoring, evaluation, data analysis and use, and other research needs. D4I is an associate award of the MEASURE Evaluation Phase IV project and is a cross-bureau global health mechanism that supports Missions across health sectors. D4I builds on and reinforces current U.S. government efforts to support countries to generate and use high quality data as evidence to improve programs, policies, and outcomes (https://www.data4impactproject.org). D4I will continue the work of MEASURE Evaluation Phase IV around evaluation, data quality and data use (the specific services are listed below) through the adaptation and use of tools and methodologies developed by MEASURE Evaluation Phase IV and through development of new ones as needed.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
51000
|
University, college or other t...eaching institution, research institute or think-tank
more
|
University of North Carolina, ...Chapel Hill
more
|
|
|
|
65679202212eaade2e0ec6a3
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019273B
|
76_60506
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.0875
|
0
|
0
|
0
|
0.0875
|
0
|
0
|
|
|
0.0875
|
Communicable diseases
|
Tuberculosis
|
100
|
ENGAGE HCD (HUMAN-CENTERED DES...IGN)
more
|
Engage HCD (Human-Centered Des...ign)
more
|
EngageHCD is a contracting veh...icle available to USAID's Bureau for Global Health and Missions to procure state-of-the-art human-centered design services. Design is a methodology that places people and other critical stakeholders at the center of the design and implementation process. The design methodology s approach to problem solving is iterative, measurable, results-driven, and interdisciplinary. It can help find solutions to issues that are ingrained in global health, such as (i) complexity of navigating and coordinating stakeholder ecosystems, (ii) difficulty in changing user behaviors, (iii) barriers to scaling compelling solutions, (iv) introducing new capabilities and collaboration models through co-creation, and (v) strengthening strategy and implementation planning. Design can drive impact and serve as a complement to our existing programs and partners through accelerating human-centered innovation. For more information on the use of design in global health, see http://www.engagehcd.com/ and https://www.designforhealth.org/. The implementing partners of this mechanism are a consortium of Lunar, Veryday, Matchboxology, PATH, and McKinsey Digital Labs. These partners bring impressive expertise across the intersection of design and global health. Lunar, McKinsey Digital Labs, and Veryday are design studios within McKinsey&Company, and together, constitute one of the largest design firms globally. Matchboxology is Africa s first design firm with over a decade of public health and development experience in the continent. PATH is a trusted partner of governments and communities in 50+countries with a wealth of global health-centric design. This consortium represents a cross-disciplinary team including anthropologists, designers, human-factor engineers, business-model designers, digital experts, and behavior change experts. The mechanism is available for both headquarter and mission buy-in. We encourage proposals and look forward to working with both our Washingt
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
McKinsey & Company, Inc.
|
|
|
|
65679202212eaade2e0ec6a4
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019312Q
|
76_60536
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
D01
|
0.086729
|
0.16377
|
0
|
0
|
0.086729
|
0.16377
|
0
|
|
|
0.086729
|
Communicable diseases
|
Tuberculosis
|
100
|
ENVIRONMENTAL COMPLIANCE SUPPO...RT CONTRACT (ECOS)
more
|
Environmental Compliance Suppo...rt Contract (ECOS)
more
|
USAID's Global Environmental C...ompliance Support Contract (ECOS) is a global activity managed by USAID's Bureau for Economic, Education, and Environment (E3). It provides on-demand environmental compliance, management, and design support to USAID's Environmental Officers, individual agency operating units, and their projects and programs.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
ICF International
|
|
|
|
65679202212eaade2e0ec6a5
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019406H
|
76_60698
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.025
|
0.222748
|
0
|
0
|
0.025
|
0.222748
|
0
|
|
|
0.025
|
Communicable diseases
|
Tuberculosis
|
100
|
GLOBAL HEALTH TECHNICAL PROFES...SIONALS (GHTP) PROGRAM
more
|
Global Health Technical Profes...sionals (GHTP) program
more
|
The Global Health Technical Pr...ofessionals (GHTP), a project of the U.S. Agency for International Development (USAID), supports the Global Health Bureaus commitment to improving global health outcomes in communities around the world by providing technical professionals at all career stages for posts both in Washington, D.C. and abroad. These global health professionals augment the Agencys programs addressing its three strategic priorities: preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and, combating infectious diseases. They improve the technical abilities of USAID offices, teams and working groups by bolstering technical leadership, accelerating innovation, increasing science and technology capabilities, strengthening local capacities, promoting gender equality, and providing acquisition and additional services on a variety of global health program initiatives
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Credence Management Solutions,... LLC
more
|
|
|
|
65679202212eaade2e0ec6a6
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019599A
|
76_60956
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
1.5
|
0.529921
|
0
|
0
|
1.5
|
0.529921
|
0
|
|
|
1.5
|
Communicable diseases
|
Tuberculosis
|
100
|
INFECTIOUS DISEASE DETECTION A...ND SURVEILLANCE (IDDS)
more
|
Infectious Disease Detection a...nd Surveillance (IDDS)
more
|
The Infectious Disease Detecti...on and Surveillance (IDDS) contract is a cross-Infectious Disease Office activity with the purpose of operationalizing global and U.S. Government initiatives and strategies aimed to reduce global health threats posed by infectious diseases, including the Global Health Security Agenda (GHSA) and tuberculosis (TB). IDDS will directly contribute to the goals and strategic objectives of USAID s Infectious Disease Office in the GH Bureau, including GHSA, TB, Emerging Threats, Neglected Tropical Diseases and Malaria.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Enterprise - United States Red...acted
more
|
|
|
|
65679203212eaade2e0ec6a7
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019669O
|
76_61032
|
3
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0
|
0.00019
|
0
|
0
|
0
|
0.00019
|
0
|
|
|
|
Communicable diseases
|
Tuberculosis
|
100
|
LEAP III: LEARNING, EVALUATION..., AND ANALYSIS PROJECT
more
|
LEAP III: Learning, Evaluation..., and Analysis Project
more
|
The LEAP III Project is a mech...anism for United State Agency for International Development (USAID) field missions and bureaus to easily and cost-effectively access rigorous, independent, and high-quality analytical services to support economic and policy analyses, strategy and project design, monitoring and evaluation, training, and knowledge management. LEAP III provides field support for analytical staff when specialized expertise in an area of analysis is required. It also provides a vehicle for USAID to support capacity building for USAID staff, partner governments, and civil society counterparts. Assistance can be provided across all sectors, including economic growth, agriculture, education, womens empowerment, environment and infrastructure. Under LEAP III, missions can request a range of analytical services, including: Cost-Benefit and Cost-Effectiveness Analysis, Macroeconomic and Public Financial Management Analysis, Performance Evaluations, Impact Evaluations, Policy Analysis Matrix Methodology, Inclusive Growth Diagnostics, and Political Economy Analysis.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
Integra, LLC
|
|
|
|
65679203212eaade2e0ec6a8
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019763F
|
76_61158
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.425
|
0.198413
|
0
|
0
|
0.425
|
0.198413
|
0
|
|
|
0.425
|
Communicable diseases
|
Tuberculosis
|
100
|
MEDICINES, TECHNOLOGIES, AND P...HARMACEUTICAL SERVICES (MTAPS)
more
|
Medicines, Technologies, and P...harmaceutical Services (MTaPS)
more
|
The goal of MTaPS is to enable... low- and middle-income countries to strengthen their pharmaceutical systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, and affordable essential medical products and medicines-related pharmaceutical services. The purpose of MTaPS is to provide pharmaceutical system strengthening assistance for sustained improvements in health system performance, and to advance USAID s goals of Preventing Child and Maternal Deaths, Controlling the HIV/AIDS Epidemic, and Combatting Infectious Disease Threats, as well as expanding essential health coverage. MTaPS works to strengthen essential areas of the pharmaceutical sector, including regulatory capacity, supply chain management, pharmaceutical financing and services, and pharmaceutical management information systems. Within this context, MTaPS addresses USG priority health elements including malaria, HIV/AIDS, family planning and reproductive health, tuberculosis, maternal and child health, neglected tropical diseases, and the Global Health Security Agenda (GHSA). MTaPS focuses on enhancing pharmaceutical services through patient-centered solutions while continuing to support essential supply chain functions and medical products supply security. The MTaPS result areas address the five health systems components (governance, human resources, information, financing, and service delivery) as they pertain to pharmaceutical management, informing the design of potential interventions to ensure that they respond to health element and cross-cutting concerns in support of health system strengthening.
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
22000
|
Donor country-based NGO
|
Management Sciences for Health
|
|
|
|
65679203212eaade2e0ec6a9
|
2020
|
United States
|
Agency for International Devel...opment
more
|
2020019962N
|
76_61555
|
1
|
Developing countries, unspecif...ied
more
|
Regional and Unspecified
|
Part I unallocated by income
|
ODA Grants
|
1
|
10
|
110
|
C01
|
0.04665
|
0.045971
|
0
|
0
|
0.04665
|
0.045971
|
0
|
|
|
0.04665
|
Communicable diseases
|
Tuberculosis
|
100
|
PROGRAM MANAGEMENT SUPPORT SER...VICES
more
|
Program Management Support Ser...vices
more
|
Program Management Support Ser...vices
more
|
0
|
12263
|
Tuberculosis control
|
|
I.2.b. Basic Health
|
61000
|
Private sector in provider cou...ntry
more
|
AT&T Inc.
|
|
|
